Answers are grounded in this paper and cite their sources.
Comment on: Distinct β-cell defects in impaired fasting glucose and impaired glucose tolerance. [Diabetes. 2012] First paragraph: β-Cell function should be expressed as insulin secretion in relation to the prevailing and changing glucose concentration and interpreted in light of prevailing insulin resistance. Characterizing alterations in β-cell function in individuals with impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) (collectively termed “prediabetes”) has been a hotly pursued topic among clinical investigators over the past several years. Because IFG and IGT are both associated with elevated risk of progression to overt type 2 diabetes and cardiovascular events (1–3), it is important to understand the specific defects in β-cell function that occur in these settings. Such knowledge could translate into targeted therapeutic interventions that could potentially delay or halt the progression of IFG/IGT to frank diabetes.
No takes yet. Share an insight, caveat, or question.
Basu et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: